GB0806746D0 - Membrane - Google Patents

Membrane

Info

Publication number
GB0806746D0
GB0806746D0 GBGB0806746.4A GB0806746A GB0806746D0 GB 0806746 D0 GB0806746 D0 GB 0806746D0 GB 0806746 A GB0806746 A GB 0806746A GB 0806746 D0 GB0806746 D0 GB 0806746D0
Authority
GB
United Kingdom
Prior art keywords
membrane
cells
useful
treatment
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0806746.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB0806746.4A priority Critical patent/GB0806746D0/en
Publication of GB0806746D0 publication Critical patent/GB0806746D0/en
Priority to ES09732279.6T priority patent/ES2665284T3/es
Priority to RU2010144399/10A priority patent/RU2530169C2/ru
Priority to BRPI0910936A priority patent/BRPI0910936A2/pt
Priority to CN200980113395.3A priority patent/CN102016009B/zh
Priority to NZ587753A priority patent/NZ587753A/en
Priority to MX2010011232A priority patent/MX2010011232A/es
Priority to KR1020107022953A priority patent/KR101317094B1/ko
Priority to PCT/GB2009/000917 priority patent/WO2009127809A1/en
Priority to EP09732279.6A priority patent/EP2265711B1/en
Priority to CA2720264A priority patent/CA2720264C/en
Priority to DK09732279.6T priority patent/DK2265711T3/en
Priority to KR1020137014211A priority patent/KR20130065737A/ko
Priority to US12/933,694 priority patent/US8642072B2/en
Priority to AU2009237462A priority patent/AU2009237462B2/en
Priority to MYPI2010004529A priority patent/MY159049A/en
Priority to JP2011504521A priority patent/JP5552478B2/ja
Priority to ZA2010/06326A priority patent/ZA201006326B/en
Priority to IL208745A priority patent/IL208745A/en
Priority to CO10142317A priority patent/CO6311115A2/es
Priority to US14/146,744 priority patent/US8889179B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0806746.4A 2008-04-14 2008-04-14 Membrane Ceased GB0806746D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB0806746.4A GB0806746D0 (en) 2008-04-14 2008-04-14 Membrane
JP2011504521A JP5552478B2 (ja) 2008-04-14 2009-04-08 膜
CA2720264A CA2720264C (en) 2008-04-14 2009-04-08 A membrane for supporting the growth of retinal pigmented epithelial cells
KR1020137014211A KR20130065737A (ko) 2008-04-14 2009-04-08 멤브레인
BRPI0910936A BRPI0910936A2 (pt) 2008-04-14 2009-04-08 membrana
CN200980113395.3A CN102016009B (zh) 2008-04-14 2009-04-08 膜
NZ587753A NZ587753A (en) 2008-04-14 2009-04-08 Membrane with retina cells
MX2010011232A MX2010011232A (es) 2008-04-14 2009-04-08 Membrana.
KR1020107022953A KR101317094B1 (ko) 2008-04-14 2009-04-08 멤브레인
PCT/GB2009/000917 WO2009127809A1 (en) 2008-04-14 2009-04-08 Membrane
EP09732279.6A EP2265711B1 (en) 2008-04-14 2009-04-08 Membrane
ES09732279.6T ES2665284T3 (es) 2008-04-14 2009-04-08 Membrana
DK09732279.6T DK2265711T3 (en) 2008-04-14 2009-04-08 CONE
RU2010144399/10A RU2530169C2 (ru) 2008-04-14 2009-04-08 Мембрана в качестве подложки для выращивания клеток ретинального пигментного эпителия (варианты), ее применение и способ засевания таких клеток
US12/933,694 US8642072B2 (en) 2008-04-14 2009-04-08 Membrane
AU2009237462A AU2009237462B2 (en) 2008-04-14 2009-04-08 Membrane
MYPI2010004529A MY159049A (en) 2008-04-14 2009-04-08 Membrane
ZA2010/06326A ZA201006326B (en) 2008-04-14 2010-09-03 Membrane
IL208745A IL208745A (en) 2008-04-14 2010-10-14 Membranes support cell growth and use
CO10142317A CO6311115A2 (es) 2008-04-14 2010-11-12 Membrana porosa no-biodegradable para soporte de crecimiento de células
US14/146,744 US8889179B2 (en) 2008-04-14 2014-01-03 Membrane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0806746.4A GB0806746D0 (en) 2008-04-14 2008-04-14 Membrane

Publications (1)

Publication Number Publication Date
GB0806746D0 true GB0806746D0 (en) 2008-05-14

Family

ID=39433610

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0806746.4A Ceased GB0806746D0 (en) 2008-04-14 2008-04-14 Membrane

Country Status (19)

Country Link
US (2) US8642072B2 (cg-RX-API-DMAC7.html)
EP (1) EP2265711B1 (cg-RX-API-DMAC7.html)
JP (1) JP5552478B2 (cg-RX-API-DMAC7.html)
KR (2) KR101317094B1 (cg-RX-API-DMAC7.html)
CN (1) CN102016009B (cg-RX-API-DMAC7.html)
AU (1) AU2009237462B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0910936A2 (cg-RX-API-DMAC7.html)
CA (1) CA2720264C (cg-RX-API-DMAC7.html)
CO (1) CO6311115A2 (cg-RX-API-DMAC7.html)
DK (1) DK2265711T3 (cg-RX-API-DMAC7.html)
ES (1) ES2665284T3 (cg-RX-API-DMAC7.html)
GB (1) GB0806746D0 (cg-RX-API-DMAC7.html)
IL (1) IL208745A (cg-RX-API-DMAC7.html)
MX (1) MX2010011232A (cg-RX-API-DMAC7.html)
MY (1) MY159049A (cg-RX-API-DMAC7.html)
NZ (1) NZ587753A (cg-RX-API-DMAC7.html)
RU (1) RU2530169C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009127809A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201006326B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110112101A1 (en) * 2009-03-05 2011-05-12 Sanofi-Aventis Treatment for ocular-related disorders
US20130108590A1 (en) * 2010-05-10 2013-05-02 Riken Method for producing cell sheet
EP3549617B1 (en) 2010-07-12 2023-09-13 University of Southern California Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
CN107937341A (zh) * 2011-02-25 2018-04-20 国立研究开发法人理化学研究所 视网膜色素上皮细胞片层的生产方法
US10478206B2 (en) 2011-04-29 2019-11-19 University Of Southern California Instruments and methods for the implantation of cell-seeded substrates
US8877489B2 (en) 2011-12-05 2014-11-04 California Institute Of Technology Ultrathin parylene-C semipermeable membranes for biomedical applications
WO2012177968A1 (en) * 2011-06-22 2012-12-27 The Schepens Eye Research Institute, Inc. A scaffold for subretinal cell transplantation and drug delivery
US9763777B2 (en) 2011-07-11 2017-09-19 Ear Science Institute Australia Device for ear drum repair
CN103007355B (zh) * 2011-09-20 2014-08-13 同济大学 一种水凝胶-纳米纤维膜及其制备方法和用途
CA2792081C (en) * 2011-10-11 2020-10-27 Bond University Ltd Layered compositions comprising 3d nanofibre webbing for tissue repair
HUE044778T2 (hu) 2011-11-14 2019-11-28 Astellas Inst For Regenerative Medicine Humán RPE sejt gyógyászati készítmények és alkalmazásaik
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
US20130330825A1 (en) * 2012-06-07 2013-12-12 City Of Hope Attachment substrates for directed differentiation of human embryonic stem cells in culture
CN113088481A (zh) 2012-08-24 2021-07-09 独立行政法人理化学研究所 用于生产视网膜色素上皮细胞片层的方法
RU2518972C1 (ru) * 2012-12-24 2014-06-10 Общество с ограниченной ответственностью "НАНО КАСКАД" Трековая мембрана для фильтрации крови
WO2015087231A1 (en) 2013-12-11 2015-06-18 Pfizer Limited Method for producing retinal pigment epithelial cells
CN105013010B (zh) * 2015-07-07 2018-01-12 中山大学中山眼科中心 一种辅助iPS‑RPE移植的层粘连蛋白膜
CN105597145A (zh) * 2016-02-22 2016-05-25 中山大学中山眼科中心 一种视网膜细胞支架生物手术粘合剂及其制备方法
KR20190022563A (ko) * 2016-06-28 2019-03-06 고쿠리츠겐큐가이하츠호징 노우교 · 쇼쿠힝 산교기쥬츠 소고겐큐기코 세포 봉입용 디바이스 및 그 사용
AU2019333301B2 (en) 2018-08-31 2025-09-25 Wisconsin Alumni Research Foundation Generating arterial endothelial cell-seeded vascular grafts
CA3137528A1 (en) * 2019-04-26 2020-10-29 Riken Composite including neural retina, retinal pigment epithelial cells, and hydrogel, and method for producing same
RU2704094C1 (ru) * 2019-05-16 2019-10-23 федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ трансплантации ретинального пигментного эпителия в форме многоклеточных 3D сфероидов в эксперименте
JP2021141877A (ja) * 2020-03-13 2021-09-24 大日本印刷株式会社 細胞培養基材、細胞付細胞培養基材、細胞培養容器、細胞付細胞培養容器、上皮細胞シート及びその製造方法、被験物質の評価方法並びに評価キット
JP7676135B2 (ja) * 2020-12-14 2025-05-14 日本バイリーン株式会社 細胞培養担体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0118984D0 (en) * 2001-08-03 2001-09-26 Intercytex Ltd Fusion of cells
CN1739813A (zh) * 2005-09-15 2006-03-01 上海赐人合元企业发展有限公司 组织工程表皮替代物及其制备方法
KR100901343B1 (ko) 2007-07-23 2009-06-05 (주)실리콘화일 결정질 반도체 박막 제조 방법
RU2368359C1 (ru) * 2008-07-22 2009-09-27 Государственное учреждение "УФИМСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ГЛАЗНЫХ БОЛЕЗНЕЙ" Академии наук Республики Башкортостан (УфНИИ ГБ АН РБ) Способ лечения возрастной макулярной дегенерации

Also Published As

Publication number Publication date
BRPI0910936A2 (pt) 2015-10-06
US8889179B2 (en) 2014-11-18
CO6311115A2 (es) 2011-08-22
NZ587753A (en) 2012-07-27
KR20130065737A (ko) 2013-06-19
CA2720264C (en) 2016-09-27
ZA201006326B (en) 2011-09-28
US20140127282A1 (en) 2014-05-08
US20110236464A1 (en) 2011-09-29
DK2265711T3 (en) 2018-04-30
IL208745A0 (en) 2010-12-30
KR101317094B1 (ko) 2013-10-16
US8642072B2 (en) 2014-02-04
RU2530169C2 (ru) 2014-10-10
CN102016009B (zh) 2015-05-20
CN102016009A (zh) 2011-04-13
ES2665284T3 (es) 2018-04-25
IL208745A (en) 2015-04-30
MX2010011232A (es) 2011-02-23
JP2011517696A (ja) 2011-06-16
AU2009237462A1 (en) 2009-10-22
WO2009127809A1 (en) 2009-10-22
KR20100128329A (ko) 2010-12-07
RU2010144399A (ru) 2012-05-20
EP2265711A1 (en) 2010-12-29
AU2009237462B2 (en) 2012-12-20
MY159049A (en) 2016-12-15
CA2720264A1 (en) 2009-10-22
JP5552478B2 (ja) 2014-07-16
EP2265711B1 (en) 2018-03-07

Similar Documents

Publication Publication Date Title
GB0806746D0 (en) Membrane
MX2011011402A (es) Sistemas, metodos y composiciones para optimizar injertos enriquecidos con celulas y tejidos.
MY158160A (en) Improved isoprene production using the dxp and mva pathway
WO2012006440A3 (en) Endothelial cell production by programming
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
MX2013009175A (es) Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
EP4585589A3 (en) Stem cell cultures
MY152114A (en) Novel pyrazole-4-n-alkoxycarboxamides as microbiocides
PH12012500818A1 (en) Pluripotent stem cells
EA201070605A1 (ru) Применение бактерий для производства биоэнергии
WO2009151907A3 (en) Compositions and methods for using cells to treat heart tissue
EA201270280A1 (ru) Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
WO2010078952A3 (de) Strukturierte gasdiffusionselektrode für elektrolysezellen
MY182946A (en) Production of organic acids by fermentation at low ph
TN2011000355A1 (en) Novel microbiocides
MY159244A (en) Method of reducing intraocular pressure in humans
EA201101626A1 (ru) Бактерии с высокоэффективным метаболизмом
EA201171141A1 (ru) Твердый ретигабин в некристаллической форме
MX336392B (es) Derivados de hidroximoil-heterociclos fungicidas.
MX2011013790A (es) Derivados de flavina.
TN2011000531A1 (en) 5- alkynyl - pyridines
WO2012016172A3 (en) Genetically modified microbes producing increased levels of acetyl-coa derived compounds
MX337070B (es) Método para preparar un conjugado klh-egfrviii.
UA103197C2 (uk) Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами
IN2012DN01223A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)